High Net Worth Advisory Group LLC
- SEC CIK
- 0001919142
- Latest filing
- Jul 29, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by High Net Worth Advisory Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −5,000−100.0% | Sold out | Holders |
| Q4 2022 | 5,000 | $202.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,000 | $165.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,000 | $176.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 5,000 | $230.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 5,000 | $332.0K | 0.1% | – | No prior filing | Holders |